Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes

BACKGROUND: Atherosclerosis and inflammation are more common in patients with diabetes than in patients without diabetes, and atherosclerosis progression contributes to inflammation. Therefore, anti-inflammatory therapy is important for the prognosis of patients with diabetes. Linagliptin is the onl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflamm Regen
Main Authors: Yamadera, Shiho, Nakamura, Yuya, Inagaki, Masahiro, Kenmotsu, Sachiyo, Nohara, Tetsuhito, Sato, Naoki, Oguchi, Tatsunori, Tsuji, Mayumi, Ohsawa, Isao, Gotoh, Hiromichi, Goto, Yoshikazu, Yura, Akihiko, Kiuchi, Yuji, Iwai, Shinichi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6100723/
https://ncbi.nlm.nih.gov/pubmed/30151063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41232-018-0071-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados